↓ Skip to main content

MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension

Overview of attention for article published in Revista Brasileira de Cirurgia Cardiovascular, January 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNAs and mesenchymal stem cells: hope for pulmonary hypertension
Published in
Revista Brasileira de Cirurgia Cardiovascular, January 2015
DOI 10.5935/1678-9741.20150033
Pubmed ID
Authors

Zhaowei Zhu, Zhenfei Fang, Xinqun Hu, Shenghua Zhou

Abstract

Pulmonary hypertension is a devastating and refractory disease and there is no cure for this disease. Recently, microRNAs and mesenchymal stem cells emerged as novel methods to treat pulmonary hypertension. More than 20 kinds of microRNAs may participate in the process of pulmonary hypertension. It seems microRNAs or mesenchymal stem cells can ameliorate some symptoms of pulmonary hypertension in animals and even improve heart and lung function during pulmonary hypertension. Nevertheless, the relationship between mesenchymal stem cells, microRNAs and pulmonary hypertension is not clear. And the mechanisms underlying their function still need to be investigated. In this study we review the recent findings in mesenchymal stem cells - and microRNAs-based pulmonary hypertension treatment, focusing on the potential role of microRNAs regulated mesenchymal stem cells in pulmonary hypertension and the role of exosomes between mesenchymal stem cells and pulmonary hypertension.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 1 4%
Student > Bachelor 1 4%
Student > Ph. D. Student 1 4%
Student > Master 1 4%
Professor > Associate Professor 1 4%
Other 0 0%
Unknown 23 82%
Readers by discipline Count As %
Social Sciences 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Agricultural and Biological Sciences 1 4%
Medicine and Dentistry 1 4%
Unknown 23 82%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2015.
All research outputs
#8,262,981
of 25,374,917 outputs
Outputs from Revista Brasileira de Cirurgia Cardiovascular
#55
of 363 outputs
Outputs of similar age
#105,035
of 359,530 outputs
Outputs of similar age from Revista Brasileira de Cirurgia Cardiovascular
#5
of 22 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 363 research outputs from this source. They receive a mean Attention Score of 2.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.